India, Jan. 31 -- India's pharmaceutical sector, valued at approximately $31 billion in 2023, holds immense promise, evolving rapidly to claim its place as a cornerstone of the global healthcare landscape. With a projected annual growth rate of 10-12 per cent, the industry aims to reach a market size of approx. $33 billion by 2025. India supplies 31 per cent of US pharmaceutical imports and boasts a 15 per cent growth rate in exports, solidifying its position as a leader in affordable medicine.

These figures emphasise both opportunities and challenges that demand a sharp focus on operational excellence (OpEx). Reflecting on the industry's growth trajectory, one cannot overlook its resilience in addressing domestic demand while expanding ...